Danicopan
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Advancing treatment goals for paroxysmal nocturnal hemoglobinuria to align with quality of life improvements in the era of anti-complement therapy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: January 12, 2026
Systemic medications and their impact on age-related macular degeneration development and progression: a review of current evidence.
Journal: Current opinion in ophthalmology
Published: January 02, 2026
New Anticomplement Drugs in Nephrology - Mechanism and Indication.
Journal: Kidney & blood pressure research
Published: November 28, 2025
Population PK-PD Modeling of Danicopan Add-On Therapy in Participants With Paroxysmal Nocturnal Hemoglobinuria Treated With Ravulizumab or Eculizumab.
Journal: CPT: pharmacometrics & systems pharmacology
Published: November 04, 2025
Progress in the use of biological therapies to treat paroxysmal nocturnal hemoglobinuria: focus on patient profiling.
Journal: Expert opinion on biological therapy
Published: October 13, 2025
Complement factor D is a drug target for metabolic-associated fatty liver disease.
Journal: Molecular immunology
Published: October 09, 2025
Challenges in optimizing targeted complement inhibitor therapy for paroxysmal nocturnal hemoglobinuria in an expanding treatment landscape
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025
Successful switch from pegcetacoplan to iptacopan after repeated severe breakthrough hemolysis events - case report.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 20, 2025
New treatment strategies for paroxysmal nocturnal hemoglobinuria: drug selection in the era of novel complement inhibitors
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: September 03, 2025
Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications.
Journal: Current therapeutic research, clinical and experimental
Published: August 07, 2025
Neuromuscular junction and the complement system.
Journal: International review of neurobiology
Published: July 17, 2025
Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience.
Journal: American journal of hematology
Published: July 17, 2025
Last Updated: 04/28/2026